600196.SS · 复星医药
China A-shares · RS rating 65 · As of 2026-10-14
| Price | 23.27 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 85 / 54 / 34 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 32 / 24 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -17.9% |
| Distance from 52-week high | +23.3% |
| Market cap (USD) | $9.5B |